Arab Republic of Egypt - Health Survey for the Egyptian Households 2021
Reference ID | EGY-CAPMAS-EFHS2021-v02 |
Year | 2021 |
Country | Arab Republic of Egypt |
Producer(s) | CAPMAS |
Sponsor(s) | Egyptian Government - - |
Collection(s) |
Created on
Oct 18, 2023
Last modified
Oct 18, 2023
Page views
576175
Brand name of pills reported
(Q306)
File: KIDS
File: KIDS
Overview
Type:
Discrete Format: numeric Width: 2 Decimals: 0 Range: 1-98 | Valid cases: 3584 Invalid: 12212 |
Value | Category | Cases | |
---|---|---|---|
1 | Microcept | 1258 | 35.1% |
2 | Microlut | 303 | 8.5% |
3 | Levonor | 362 | 10.1% |
4 | Triocept | 66 | 1.8% |
5 | Gynera | 607 | 16.9% |
6 | Nordette | 9 | 0.3% |
7 | Exluton | 140 | 3.9% |
8 | Marvelon | 16 | 0.4% |
9 | Cilest | 29 | 0.8% |
10 | Cotrablan | 9 | 0.3% |
96 | Other | 447 | 12.5% |
98 | Don't know | 338 | 9.4% |
Sysmiss | 12212 |
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.